Hydrocephalus Shunt Market
Hydrocephalus Shunt Market Forecasts to 2030 - Global Analysis By Product (Hydrocephalus Catheter, Hydrocephalus Valves and Other Products), Shunt Type (Ventriculopleural Shunts, Lumboperitoneal Shunts, Ventriculoatrial Shunts, Ventriculoperitoneal Shunts and Other Shunt Types), Age Group (Adult and Pediatric), End User (Ambulatory Surgical Centers, Hospitals and Other End Users) and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $322.2 MN |
|
Projected Year Value (2030) |
US $487.6 MN |
|
CAGR (2023 - 2030) |
6.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Hydrocephalus Shunt Market is accounted for $322.2 million in 2023 and is expected to reach $487.6 million by 2030 growing at a CAGR of 6.1% during the forecast period. An apparatus used in clinical practice to help treat a mental illness involving excessive cerebrospinal fluid collection is referred to as a hydrocephalus shunt. An expanded intracranial pressing factor is the result of this condition in the skull. The fluid collection caused by these devices helps reduce stress in the brain. Shunts are surgically implanted devices designed to divert excess cerebrospinal fluid from the brain to another part of the body, typically the abdominal cavity, where it can be absorbed naturally.
According to an article published by the American Society for Biochemistry and Molecular Biology in March 2021, in the United States, about 2.8 million people sustain a traumatic brain injury (TBI) every year, with some 280,000 resulting in hospitalizations.
Market Dynamics:
Driver:
Advancements in shunt technology
The advancements encompass a wide range of improvements, including the development of programmable and adjustable shunt systems, utilization of novel materials for improved biocompatibility and longevity, and the introduction of minimally invasive surgical techniques. Programmable shunts offer the ability to adjust flow settings post-implantation, providing greater flexibility in managing patients' hydrocephalus symptoms. Additionally, the integration of innovative materials into shunt designs enhances their performance and reduces the risk of complications such as infection and blockage.
Restraint:
Cost constraints
Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid in the brain, often requires surgical intervention with shunt devices to alleviate symptoms. The high cost associated with shunt placement, including surgery, device implantation, and ongoing maintenance, poses financial burdens for patients and healthcare providers alike. However, limited insurance coverage, particularly in regions with inadequate healthcare infrastructure, further exacerbates the issue, potentially delaying or denying access to essential treatment.
Opportunity:
Growing demand for minimally invasive surgical procedures
Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced trauma, faster recovery times, shorter hospital stays, and minimized risk of complications such as infection and bleeding. In the context of hydrocephalus, where patients often require shunt implantation to manage excess cerebrospinal fluid buildup, minimally invasive approaches provide a less invasive alternative to traditional methods. These techniques typically involve smaller incisions, specialized tools, and sometimes even endoscopic guidance, allowing surgeons to place shunts with greater precision and minimal disruption to surrounding tissues.
Threat:
Inadequate access to care
Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid within the brain, often requires surgical intervention with shunts to alleviate symptoms. However, disparities in healthcare infrastructure, particularly in underserved regions and developing countries, limit access to timely diagnosis, treatment, and follow-up care. Factors such as limited healthcare facilities, insufficient trained medical personnel, and financial constraints contribute to this challenge. Consequently, many individuals with hydrocephalus lack access to essential shunt surgeries or experience delays in receiving them, leading to increased morbidity and mortality rates.
Covid-19 Impact:
As healthcare systems worldwide redirected resources to combat the pandemic, elective surgeries, including those for hydrocephalus, were postponed or canceled to prioritize COVID-19 patients and minimize transmission risks. This led to a decrease in shunt implantations and replacements, resulting in a downturn in the market. Moreover, restrictions on non-essential medical procedures, coupled with patients' reluctance to visit hospitals due to fear of contracting the virus, further dampened demand.
The Hydrocephalus Catheter segment is expected to be the largest during the forecast period
Hydrocephalus Catheter segment commanded the largest share of the market over the projection period as advancements in catheter design and materials have improved the efficacy and longevity of shunt systems, enhancing patient outcomes and reducing the need for revision surgeries. The increasing prevalence of conditions such as congenital hydrocephalus and normal pressure hydrocephalus is fueling demand for effective treatment options, leading to a rising number of hydrocephalus shunt procedures worldwide. Moreover, technological innovations in catheter manufacturing have allowed for the development of minimally invasive techniques, making shunt placement procedures safer and more accessible to patients.
The Ventriculoperitoneal Shunts segment is expected to have the highest CAGR during the forecast period
Ventriculoperitoneal Shunts segment is poised to witness profitable growth during the overcast period due to its effectiveness and widespread adoption in treating hydrocephalus—a condition characterized by the accumulation of cerebrospinal fluid in the brain's ventricles. VP shunts offer a minimally invasive solution by diverting excess fluid from the brain's ventricles to the peritoneal cavity, where it can be naturally absorbed by the body. This approach not only relieves intracranial pressure but also helps alleviate symptoms associated with hydrocephalus, such as headaches, nausea, and cognitive impairment.
Region with largest share:
Because of the rising prevalence of neurological disorders, patients' preference for less invasive procedures, rising healthcare costs, and improved research and development efforts leading to advancements in shunt technology, the hydrocephalus shunts market has grown most rapidly in North America, accounting for the largest revenue share over the extrapolated period. The Centers for Medicare & Medicaid Services (CMS), for instance, projected that in 2022, health spending in the United States would be 7.5%. The first time that spending is expected to surpass $1 trillion USD is in 2023.
Region with highest CAGR:
Because of the region's improved healthcare infrastructure, rising number of surgeries, and government agreements to expand the medical device portfolio, the Asia Pacific market is expected to grow profitably over the projected period. For instance, the prime ministers of Japan and India approved a five-year financial plan and an investment of USD 42 billion in March 2022 to support a joint venture in medical equipment production. Due to rising healthcare costs, India's healthcare system is witnessing a shift in its service portfolio from nursing care to preventative care for disease control.
Key players in the market
Some of the key players in Hydrocephalus Shunt market include Aesculap, Inc, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd, Integra LifeSciences, Johnson & Johnson, Medtronic, Natus Medical Incorporated, Sophysa and Spiegelberg GmbH & Co. KG.
Key Developments:
In November 2023, for young patients suffering from hydrocephalus-a neurological disorder that results in an accumulation of cerebral fluid in the interior spaces of the brain which often requires repeated hospital stays-surgeons at Intermountain Primary Children's Hospital successfully placed a novel brain shunt accessory, becoming the first hospital in the U.S. to accomplish the same.
In October 2023, through its Blueprint MedTech initiative, the NINDS (National Institute of Neurological Disorders and Stroke) of the National Institutes of Health (NIH) awarded Rhaeos, Inc. a USD 1.5 million grant. With this award, the company will continue to develop its FDA-designated breakthrough medical technology, which aims to revolutionize the treatment of hydrocephalus, a brain disorder that affects more than a million people in the U.S.
In July 2023, Cerevasc Inc. partnered with Lianmedical Co. Ltd. to introduce its medical devices for neurological diseases in Asia. Lianmedical marketed Cerevasc's eshunt system and related products in mainland China, Hong Kong, Taiwan, and Macau, facilitating percutaneous transvenous-transdural access to the central nervous system.
Products Covered:
• Hydrocephalus Catheter
• Hydrocephalus Valves
• Other Products
Shunt Types Covered:
• Ventriculopleural Shunts
• Lumboperitoneal Shunts
• Ventriculoatrial Shunts
• Ventriculoperitoneal Shunts
• Other Shunt Types
Age Groups Covered:
• Adult
• Pediatric
End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Hydrocephalus Shunt Market, By Product
5.1 Introduction
5.2 Hydrocephalus Catheter
5.2.1 Antimicrobial Catheters
5.2.2 Standard Catheters
5.3 Hydrocephalus Valves
5.3.1 Fix Pressure Valves
5.3.2 Adjustable Pressure Valves
5.4 Other Products
6 Global Hydrocephalus Shunt Market, By Shunt Type
6.1 Introduction
6.2 Ventriculopleural Shunts
6.3 Lumboperitoneal Shunts
6.4 Ventriculoatrial Shunts
6.5 Ventriculoperitoneal Shunts
6.6 Other Shunt Types
7 Global Hydrocephalus Shunt Market, By Age Group
7.1 Introduction
7.2 Adult
7.3 Pediatric
8 Global Hydrocephalus Shunt Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Other End Users
9 Global Hydrocephalus Shunt Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Aesculap, Inc
11.2 B. Braun Melsungen AG
11.3 Christoph Miethke GmbH & Co. KG
11.4 G. Surgiwear Ltd
11.5 Integra LifeSciences
11.6 Johnson & Johnson
11.7 Medtronic
11.8 Natus Medical Incorporated
11.9 Sophysa
11.10 Spiegelberg GmbH & Co. KG
List of Tables
1 Global Hydrocephalus Shunt Market Outlook, By Region (2021-2030) ($MN)
2 Global Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
3 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
4 Global Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
5 Global Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
6 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
7 Global Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
8 Global Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
9 Global Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
10 Global Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
11 Global Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
12 Global Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
13 Global Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
14 Global Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
15 Global Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
16 Global Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
17 Global Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
18 Global Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
19 Global Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
20 Global Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
21 Global Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
22 Global Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
23 North America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
24 North America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
25 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
26 North America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
27 North America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
28 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
29 North America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
30 North America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
31 North America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
32 North America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
33 North America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
34 North America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
35 North America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
36 North America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
37 North America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
38 North America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
39 North America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
40 North America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
41 North America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
42 North America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
43 North America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
44 North America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
45 Europe Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
46 Europe Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
47 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
48 Europe Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
49 Europe Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
50 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
51 Europe Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
52 Europe Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
53 Europe Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
54 Europe Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
55 Europe Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
56 Europe Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
57 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
58 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
59 Europe Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
60 Europe Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
61 Europe Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
62 Europe Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
63 Europe Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
64 Europe Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
65 Europe Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
66 Europe Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
67 Asia Pacific Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
68 Asia Pacific Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
69 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
70 Asia Pacific Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
71 Asia Pacific Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
72 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
73 Asia Pacific Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
74 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
75 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
76 Asia Pacific Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
77 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
78 Asia Pacific Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
79 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
80 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
81 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
82 Asia Pacific Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
83 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
84 Asia Pacific Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
85 Asia Pacific Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
86 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
87 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
88 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
89 South America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
90 South America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
91 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
92 South America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
93 South America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
94 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
95 South America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
96 South America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
97 South America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
98 South America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
99 South America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
100 South America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
101 South America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
102 South America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
103 South America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
104 South America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
105 South America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
106 South America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
107 South America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
108 South America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
109 South America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
110 South America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
111 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
112 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
113 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
114 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
115 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
116 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
117 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
118 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
119 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
120 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
121 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
122 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
123 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
124 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
125 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
126 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
127 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
128 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
129 Middle East & Africa Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
130 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
131 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
132 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
